½ÃÀ庸°í¼­
»óǰÄÚµå
1090131

¼¼°èÀÇ ¹®Çձ⠽ÃÀå ±Ô¸ð : Á¦Ç° À¯Çüº°(ÀÏȸ¿ë, ÀçÀÌ¿ë °¡´É), ¿ëµµº°(½ÉÀåÇ÷°ü ¿Ü°ú, ¼ÒÈ­±â ¿Ü°ú, ±âŸ), ÃÖÁ¾»ç¿ëÀÚº°(º´¿ø, ¿Ü·¡Áø·á¼¾ÅÍ£¦Å¬¸®´Ð), Áö¿ªº° ¿¹Ãø(2022-2028³â)

Global Anastomosis Devices Market Size study, by Product Type (Disposable, Reusable) by Application (Cardiovascular Surgery, Gastrointestinal Surgery, Others) by End-user (Hospitals, Ambulatory Care Centers & Clinics) and Regional Forecasts 2022-2028

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Bizwit Research & Consulting LLP | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ¹®Çձ⠽ÃÀå ±Ô¸ð´Â 2021³âÀº ¾à 33¾ï 9,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾úÀ¸¸ç, 2022-2028³â°£ 5.60% ÀÌ»óÀÇ ¼ºÀå·ü·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÀÌ·¯ÇÑ ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇÏ´Â ÁÖ¿äÀÎÀ¸·Î´Â ½ÉÀåÇ÷°üÀ̳ª À§À庴 Áõ°¡, »õ·Î¿î ¹®ÇÕ±âÀÇ ¹ßÀü µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. ÇÑÆí, µð¹ÙÀ̽ºÀÇ °íºñ¿ë°ú ½ÅÁ¦Ç° Ãâ½Ã¸¦ À§ÇÑ »ó´çÇÑ ÀÓ»ó µ¥ÀÌÅÍ ¿ä°Ç µîÀÌ ½ÃÀå ¼ºÀåÀ» ¾ïÁ¦ÇÒ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù.

¼¼°èÀÇ ¹®ÇÕ±â(Anastomosis Devices) ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä, ½ÃÀå ºÐ¼®, Á¦Ç° À¯Çü¡¤¿ëµµ¡¤ÃÖÁ¾»ç¿ëÀÚ¡¤Áö¿ªº° ºÐ¼® ¹× °æÀï ±¸µµ µîÀÇ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå ¼¼°èÀÇ ¹®Çձ⠽ÃÀå Á¤ÀÇ¿Í ¹üÀ§

Á¦3Àå ¼¼°èÀÇ ¹®Çձ⠽ÃÀå ¿ªÇÐ

  • ¹®Çձ⠽ÃÀå ¿µÇ⠺м®(2020-2028³â)

Á¦4Àå ¼¼°èÀÇ ¹®Çձ⠽ÃÀå : ¾÷°è ºÐ¼®

  • Porter's Five Forces ¸ðµ¨
  • PEST ºÐ¼®
  • ÅõÀÚ Ã¤¿ë ¸ðµ¨
  • ¾Ö³Î¸®½ºÆ®ÀÇ Ãßõ »çÇ×°ú °á·Ð
  • ÁÖ¿ä ÅõÀÚ ±âȸ
  • ÁÖ¿ä ¼º°ø Àü·«

Á¦5Àå ¸®½ºÅ© Æò°¡ : COVID-19ÀÇ ¿µÇâ

    • ¾÷°è¿¡ ´ëÇÑ COVID-19ÀÇ ÀüüÀûÀÎ ¿µÇâ Æò°¡
    • COVID-19 ÀÌÀü ¹× COVID-19 ÀÌÈÄÀÇ ½ÃÀå ½Ã³ª¸®¿À

Á¦6Àå ¼¼°èÀÇ ¹®Çձ⠽ÃÀå : Á¦Ç° À¯Çüº°

  • ½ÃÀå ÇöȲ
  • Á¦Ç° À¯Çüº° ¼¼°èÀÇ ¹®Çձ⠽ÃÀå ½ÇÀû-ÀáÀ缺 ºÐ¼®
  • Á¦Ç° À¯Çüº° ¼¼°èÀÇ ¹®Çձ⠽ÃÀå ÃßÁ¤°ú ¿¹Ãø(2018-2028³â)
  • ¹®Çձ⠽ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
    • ÀÏȸ¿ë
    • ÀçÀÌ¿ë °¡´É

Á¦7Àå ¼¼°èÀÇ ¹®Çձ⠽ÃÀå : ¿ëµµº°

  • ½ÃÀå ÇöȲ
  • ¿ëµµº° ¼¼°èÀÇ ¹®Çձ⠽ÃÀå ½ÇÀû-ÀáÀ缺 ºÐ¼®
  • ¿ëµµº° ¼¼°èÀÇ ¹®Çձ⠽ÃÀå ÃßÁ¤°ú ¿¹Ãø(2018-2028³â)
  • ¹®Çձ⠽ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
    • ½ÉÀåÇ÷°ü ¿Ü°ú
    • ¼ÒÈ­±â ¿Ü°ú
    • ±âŸ

Á¦8Àå ¼¼°èÀÇ ¹®Çձ⠽ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ½ÃÀå ÇöȲ
  • ÃÖÁ¾»ç¿ëÀÚº° ¼¼°èÀÇ ¹®Çձ⠽ÃÀå ½ÇÀû-ÀáÀ缺 ºÐ¼®
  • ÃÖÁ¾»ç¿ëÀÚº° ¼¼°èÀÇ ¹®Çձ⠽ÃÀå ÃßÁ¤°ú ¿¹Ãø(2018-2028³â)
  • ¹®Çձ⠽ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
    • º´¿ø
    • ¿Ü·¡Áø·á¼¾ÅÍ£¦Å¬¸®´Ð

Á¦9Àå ¼¼°èÀÇ ¹®Çձ⠽ÃÀå : Áö¿ªº°

  • Áö¿ª ½ÃÀå ÇöȲ
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´ ÇöȲ
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç ÇöȲ
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä« ÇöȲ
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
  • ±âŸ Áö¿ª

Á¦10Àå °æÀï Á¤º¸

  • ÁÖ¿ä ½ÃÀå Àü·«
  • ±â¾÷ °³¿ä
    • Medtronic
    • LivaNova PLC
    • MAQUET Holding B.V. & Co. KG.
    • Dextera Surgical Inc.
    • Vitalitec Internaional Inc.
    • Synovis Micro Companies Alliance, Inc.
    • Ethicon US, LLC
    • Peters Surgical
    • Johnson & Johnson
    • B. Braun Melsungen AG

Á¦11Àå Á¶»ç ÇÁ·Î¼¼½º

LSH 22.07.07

Global Anastomosis Devices Market is valued approximately USD 3.39billion in 2021 and is anticipated to grow with a healthy growth rate of more than 5.60% over the forecast period 2022-2028. The connecting of two typically divergent structures is known as an anastomosis. Connections between blood vessels or other tubular structures, such as gut loops, are referred to as this. In the approaching years, the increased prevalence of cardiovascular and gastrointestinal illnesses is expected to drive demand for anastomosis devices. According to the World Health Organization (WHO), 17.9 million people died from cardiovascular diseases (CVD) in 2019, accounting for 32 percent of all fatalities worldwide. It further claims that strokes and heart attacks account for 85 percent of these deaths. Coronary Heart Disease/Artery Disease (CHD/CAD) is the most common type of heart disease, with about 805,000 Americans suffering from a heart attack each year.. For example, GI Windows Corp. raised $16.4 million in a Series A-1 funding round in October 2020, with participation from Johnson & Johnson Innovation and others. The funding will be used to advance the company's anastomosis technology development and clinical studies. Furthermore, the demand for better patient outcomes will boost the adoption of novel anastomosis device advancements and contribute to market growth. For example, India Medtronic Private Limited, a wholly-owned subsidiary of Medtronic, launched the EEA Circular Stapler with Tri-Staple Technology in December 2020. This is the first 3-row Circular Stapler with a wide range of staple heights that has been approved for use in colorectal surgery. However, throughout the projection period of 2022-2028, the market's growth would be hampered by the high cost of devices and the substantial clinical data requirements for releasing new products.

The key regions considered for the global Anastomosis Devices market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. Because of well-structured reimbursement regulations, a growing target population, and the presence of a significant number of essential participants on the ground, North America was in the forefront in the global arena. Due to the growing geriatric population, rising CVD incidence, rapid developments in the healthcare sector, and rising disposable income, Asia Pacific is expected to grow at a lucrative CAGR during the forecast period.

Major market player included in this report are:

Medtronic

LivaNova PLC

MAQUET Holding B.V. & Co. KG.

Dextera Surgical Inc.

Vitalitec Internaional Inc.

Synovis Micro Companies Alliance, Inc.

Ethicon US, LLC

Peters Surgical

Johnson & Johnson

B. Braun Melsungen AG

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type

Disposable

Reusable

By Application

Cardiovascular Surgery

Gastrointestinal Surgery

Others

By End-user

Hospitals

Ambulatory Care Centers & Clinics

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Anastomosis Devices Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
    • 1.2.1. Anastomosis Devices Market, by Region, 2020-2028 (USD Billion)
    • 1.2.2. Anastomosis Devices Market, by Product Type, 2020-2028 (USD Billion)
    • 1.2.3. Anastomosis Devices Market, by Application, 2020-2028 (USD Billion)
    • 1.2.4. Anastomosis Devices Market, by End-use, 2020-2028 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Anastomosis Devices Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Anastomosis Devices Market Dynamics

  • 3.1. Anastomosis Devices Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing Target Disease Prevalence and Subsequent Growth in the Number of Surgical Procedures
      • 3.1.1.2. Growing Healthcare Markets in Emerging Economies
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Devices
      • 3.1.2.2. Extensive Clinical Data Requirements for Launching New Products
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Growing Demand for Minimally Invasive Surgeries
      • 3.1.3.2. Technological Advancements in devices

Chapter 4. Global Anastomosis Devices Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Anastomosis Devices Market, by Product Type

  • 6.1. Market Snapshot
  • 6.2. Global Anastomosis Devices Market by Product Type, Performance - Potential Analysis
  • 6.3. Global Anastomosis Devices Market Estimates & Forecasts by Product Type 2018-2028 (USD Billion)
  • 6.4. Anastomosis Devices Market, Sub Segment Analysis
    • 6.4.1. Disposable
    • 6.4.2. Reusable

Chapter 7. Global Anastomosis Devices Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global Anastomosis Devices Market by Application, Performance - Potential Analysis
  • 7.3. Global Anastomosis Devices Market Estimates & Forecasts by Application 2018-2028 (USD Billion)
  • 7.4. Anastomosis Devices Market, Sub Segment Analysis
    • 7.4.1. Cardiovascular Surgery
    • 7.4.2. Gastrointestinal Surgery
    • 7.4.3. Others

Chapter 8. Global Anastomosis Devices Market, by End-user

  • 8.1. Market Snapshot
  • 8.2. Global Anastomosis Devices Market by End-use, Performance - Potential Analysis
  • 8.3. Global Anastomosis Devices Market Estimates & Forecasts by End-user 2018-2028 (USD Billion)
  • 8.4. Anastomosis Devices Market, Sub Segment Analysis
    • 8.4.1. Hospitals
    • 8.4.2. Ambulatory Care Centers & Clinics

Chapter 9. Global Anastomosis Devices Market, Regional Analysis

  • 9.1. Anastomosis Devices Market, Regional Market Snapshot
  • 9.2. North America Anastomosis Devices Market
    • 9.2.1. U.S. Anastomosis Devices Market
      • 9.2.1.1. Product Type breakdown estimates & forecasts, 2018-2028
      • 9.2.1.2. Application breakdown estimates & forecasts, 2018-2028
      • 9.2.1.3. End-user breakdown estimates & forecasts, 2018-2028
    • 9.2.2. Canada Anastomosis Devices Market
  • 9.3. Europe Anastomosis Devices Market Snapshot
    • 9.3.1. U.K. Anastomosis Devices Market
    • 9.3.2. Germany Anastomosis Devices Market
    • 9.3.3. France Anastomosis Devices Market
    • 9.3.4. Spain Anastomosis Devices Market
    • 9.3.5. Italy Anastomosis Devices Market
    • 9.3.6. Rest of Europe Anastomosis Devices Market
  • 9.4. Asia-Pacific Anastomosis Devices Market Snapshot
    • 9.4.1. China Anastomosis Devices Market
    • 9.4.2. India Anastomosis Devices Market
    • 9.4.3. Japan Anastomosis Devices Market
    • 9.4.4. Australia Anastomosis Devices Market
    • 9.4.5. South Korea Anastomosis Devices Market
    • 9.4.6. Rest of Asia Pacific Anastomosis Devices Market
  • 9.5. Latin America Anastomosis Devices Market Snapshot
    • 9.5.1. Brazil Anastomosis Devices Market
    • 9.5.2. Mexico Anastomosis Devices Market
  • 9.6. Rest of The World Anastomosis Devices Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Medtronic
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Type Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. LivaNova PLC
    • 10.2.3. MAQUET Holding B.V. & Co. KG.
    • 10.2.4. Dextera Surgical Inc.
    • 10.2.5. Vitalitec Internaional Inc.
    • 10.2.6. Synovis Micro Companies Alliance, Inc.
    • 10.2.7. Ethicon US, LLC
    • 10.2.8. Peters Surgical
    • 10.2.9. Johnson & Johnson
    • 10.2.10. B. Braun Melsungen AG

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦